Kruger-McDermott C, Johnson T B, Rej R, vanderHoeven T, Nair M G, Galivan J
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201.
Int J Cancer. 1987 Dec 15;40(6):835-9. doi: 10.1002/ijc.2910400622.
A cell line derived from H35 hepatoma cells resistant to methotrexate (MTX) as a result of a defective transport system for MTX has been examined to determine how closely the variant resembles the parent cells with regard to other biochemical properties. The capacity of extracts of resistant cells to catalyze the poly-gamma-glutamylation of MTX was approximately twice as great as that of wild-type cell extracts. Evidence of similarity between wild-type and H35 R0.3 cells was derived from the equitoxic activity to both cell lines of nonclassical antifolates and other miscellaneous antineoplastics which act by a variety of mechanisms. Two phenotypic markers of hepatic cell function, alpha-aminoisobutyric acid (AIB) transport and tyrosine aminotransferase (TAT) activity inducibility, were present in both cell types, demonstrating the maintenance of these phenotypic properties in the H35 R0.3 cells. gamma-Glutamyltransferase (GGT, EC 2.3.2.2) activity differed in that it was present in wild-type cells and barely detectable in H35 R0.3 cells. The GGT activity reappeared in the H35 cells when they regained MTX sensitivity after incubation for 14-20 weeks in MTX-free media. Although defective MTX transport appeared to be correlated with the disappearance of GGT activity in an H35 variant cell line, no functional relationship between them is apparent at this time. It is possible that a lack of GGT activity may be evidence of a more differentiated phenotype in the transport-resistant cell line.
从对甲氨蝶呤(MTX)耐药的H35肝癌细胞系中衍生出一种细胞系,该细胞系因MTX转运系统缺陷而产生耐药性。对该变异细胞系进行了检测,以确定其在其他生化特性方面与亲代细胞的相似程度。耐药细胞提取物催化MTX多聚γ-谷氨酰化的能力约为野生型细胞提取物的两倍。非经典抗叶酸药物和其他通过多种机制起作用的杂类抗肿瘤药物对两种细胞系具有同等毒性活性,这证明了野生型细胞和H35 R0.3细胞之间存在相似性。两种肝细胞功能的表型标志物,α-氨基异丁酸(AIB)转运和酪氨酸转氨酶(TAT)活性诱导性,在两种细胞类型中均存在,这表明H35 R0.3细胞中这些表型特性得以维持。γ-谷氨酰转移酶(GGT,EC 2.3.2.2)活性有所不同,野生型细胞中存在该活性,而在H35 R0.3细胞中几乎检测不到。当H35细胞在无MTX培养基中培养14 - 20周后恢复对MTX的敏感性时,GGT活性重新出现。尽管在H35变异细胞系中,MTX转运缺陷似乎与GGT活性消失相关,但目前它们之间尚无明显的功能关系。缺乏GGT活性可能是转运耐药细胞系中表型更分化的证据。